Search results for "Atopy"

showing 10 items of 99 documents

CCDC 1833441: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-((mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-lanthanum trinitrate heptahydrate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833443: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-((mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-terbium bromide trifluoromethanesulfonate hydrate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833439: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-((mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-ytterbium tribromide heptahydrate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833444: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-((mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-yttrium trinitrate pentahydrate)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 766166: Experimental Crystal Structure Determination

2011

Related Article: Peng-Fei Wang, Yan Duan, J.M.Clemente-Juan, You Song, Kang Qian, Song Gao, Li-Min Zheng|2011|Chem.-Eur.J.|17|3579|doi:10.1002/chem.201002348

Space GroupCrystallographycatena-(bis(mu5-6-phosphonatopyridine-3-carboxylato)-(mu2-11'-(14-phenylenebis(methylene))bis(1H-imidazole))-diaqua-tri-cobalt(ii))Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833436: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-[(mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-diaqua-samarium bromide trifluoromethanesulfonate undecahydrate]Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1833435: Experimental Crystal Structure Determination

2019

Related Article: Antti Tiihonen, Manu Lahtinen|2019|CrystEngComm|21|2286|doi:10.1039/C8CE01015C

Space GroupCrystallographycatena-[(mu-11'1''-[(246-trimethylbenzene-135-triyl)tris(methylene)]tris(4-carboxylatopyridin-1-ium))-triaqua-neodymium tris(trifluoromethanesulfonate) heptahydrate]Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

A 15-Year-Old Boy with Anterior Chest Pain, Progressive Dyspnea, and Subcutaneous Emphysema of the Neck

2009

We describe the case of an adolescent who was admitted to the hospital because of sudden occurrence of chest pain, dyspnea and subcutaneous emphysema. On admission, physical examination revealed subcutaneous crepitations in the superior part of the rib cage, and auscultation of the chest showed widespread wheezing. The radiological assessment confirmed the diagnosis of pneumomediastinum and pneumothorax. A follow-up CT scan performed one week after the admission showed almost complete resolution of the radiological alterations. At the following visits, the patient was asymptomatic, but reported to have suffered from frequent episodes of rhinorrea, sneezing, nasal blockage, and sometimes, ch…

Spirometrymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCase Reportdyspnea atopy asthmaPhysical examinationSettore MED/10 - Malattie Dell'Apparato RespiratorioChest painmedicine.diseaserespiratory tract diseasesSurgeryPneumothoraxAnterior chestAnesthesiamedicineImmunology and AllergyPneumomediastinummedicine.symptombusinessSubcutaneous emphysemaAsthmaJournal of Allergy
researchProduct

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis

2021

Simple Summary Atopic dermatitis, also called neurodermatitis, is one of the best-known chronic inflammatory skin diseases with eczema, strong itch and dry skin. It is based on an impaired skin barrier with changes in the fats and proteins of the horny layer, which leads to a disturbed water balance. Prurigo nodularis is a less common and intractable chronic skin disease with very itchy nodules. It can be associated with atopic dermatitis (so called atopic prurigo) or with many other diseases. The aim of this study was to compare these three skin diseases classic atopic dermatitis, atopic prurigo and non-atopic prurigo nodularis with healthy control subjects with regard to their skin barrie…

Transepidermal water lossmedicine.medical_specialtyGeneral Immunology and Microbiologyintegumentary systematopic dermatitisepidermal barrierQH301-705.5Atopic dermatitisBiologymedicine.diseaseDermatologyGeneral Biochemistry Genetics and Molecular BiologyArticleAtopybody regionsprurigo nodularisPrurigomedicineLoricrinBiology (General)General Agricultural and Biological SciencesInvolucrinPrurigo nodularisFilaggrinBiology
researchProduct

Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study

2004

BACKGROUND: Atopic dermatitis (AD) is a chronic allergic inflammatory disease, which manifests itself with eczematous skin lesions. OBJECTIVE: We compared the clinical efficacy of tacrolimus ointment (0.1%) given twice a day and oral cyclosporine (3 mg/kg) given once daily. Rescue medication for itching included cetirizine 10-20 mg (equal to one or two tables). METHODS: Thirty patients, aged 13-45 years (mean+/-SD 27.1+/-10.9), with a history of moderate-to-severe AD were randomized to treatments, 15 patients for each treatments. Assessment of efficacy was based on SCORAD, on scores of daily itching, erythema, interference with sleep, due to the skin condition and days without use of cetiri…

atopic dermatitiAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentErythemaImmunologyAdministration OralDermatitisSeverity of Illness IndexGastroenterologyDrug Administration ScheduleAtopicDermatitis AtopicOintmentsAtopyLeukocyte CountDouble-Blind MethodInternal medicinemedicineHumansImmunology and Allergy; oral cyclosporine; atopic dermatitis; randomized study [tacrolimus ointment]SCORADcetirizinetacrolimusmedicine.diagnostic_testatopic dermatitisbusiness.industryArea under the curveoral cyclosporineAtopic dermatitisImmunoglobulin EMiddle Agedmedicine.diseaseDermatologyTacrolimusCetirizineEosinophilstacrolimus ointment:CyclosporineFemaleOnset of actionmedicine.symptombusinessrandomized studyImmunosuppressive Agentsmedicine.drug
researchProduct